BioAge Labs Inc.

NASDAQ: BIOA · Real-Time Price · USD
4.49
0.03 (0.67%)
At close: Aug 15, 2025, 9:57 AM

BioAge Labs Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
354.35M 21.64M 27.64M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
100K 100K n/a
Other Long-Term Assets
240K n/a 25K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
2.75M 3.66M 386K
Total Current Assets
357.1M 25.31M 28.03M
Property-Plant & Equipment
791K 518K 374K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
1.13M 618K 399K
Total Assets
358.23M 25.92M 28.43M
Account Payables
2M 1.87M 2.26M
Deferred Revenue
7.83M 3.31M n/a
Short-Term Debt
6.2M 44.86M 167K
Other Current Liabilities
11.75M 1.39M 24K
Total Current Liabilities
27.77M 58.17M 5.86M
Long-Term Debt
2.5M 8.2M 2.25M
Other Long-Term Liabilities
156K 132.95M 132.88M
Total Long-Term Liabilities
7.33M 141.15M 135.13M
Total Liabilities
35.11M 199.32M 140.99M
Total Debt
8.7M 53.25M 2.47M
Common Stock
n/a n/a n/a
Retained Earnings
-252.81M -181.7M -117.85M
Comprehensive Income
245K 164K 167K
Shareholders Equity
323.13M -173.4M -112.56M
Total Investments
100K 100K n/a